| 1 | 2761-08-2 | ACRYLICACID,3-HYDROXYPROPYLESTER | C6H10O3 | 130.14 | | |
| 2 | 2761-09-3 | 3-hydroxypropyl methacrylate | C7H12O3 | 144.16838 | | |
| 3 | 2761-13-9 | 1,1'-(ethylene)bis[5-oxopyrrolidine-3-carboxylic] acid | C12H16N2O6 | 284.27 | | |
| 4 | 2761-15-1 | 2,4-Dihydrazino-6-methylamino-s-triazine | C4H10N8 | 170.18 | | |
| 5 | 2761-21-9 | diisocyanic acid, diester with 4-(p-hydroxybenzyl)-o-cresol | C16H12N2O2 | | | |
| 6 | 2761-22-0 | 4,4'-Biphenyldiisocyanate | C14H8N2O2 | 236.23 | 107.5-109 °C | |
| 7 | 2761-24-2 | Amyltriethoxysilane | C11H26O3Si | 234.41 | | |
| 8 | 2761-33-3 | 2H-Pyran-2-ol, tetrahydro-, acetate | C7H12O3 | 144.16838 | | |
| 9 | 2761-72-0 | Carbonochloridic acid, 4-(1-methylethenyl)phenyl ester | C10H9ClO2 | 196.63026 | | |
| 10 | 2761-77-5 | Communic acid | C20H30O2 | 302.45 | 121 °C | |
| 11 | 2761-84-4 | 5-Dodecenoic acid | C12H22O2 | 198.3 | 0.7°C | |
| 12 | 27610-07-7 | Glycine,N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl-, methyl ester | C14H26N2O5 | 302.36664 | | |
| 13 | 27610-12-4 | Equilin 3-O-β-D-Glucuronide Sodium Salt | C24H27NaO8 | 466.46 | | |
| 14 | 27610-14-6 | 3-amino-6-chloro-3,4-dihydro-4-phenylquinazolin-4-ol | C14H12ClN3O | 273.72 | | |
| 15 | 27610-15-7 | P'-Amidotriphosphoric acid (9CI) | H6NO9P3 | 256.97 | | |
| 16 | 27610-20-4 | phenylsulfanol | C6H6OS | 126.17624 | | |
| 17 | 27610-27-1 | Solerole | C6H10O4 | 130.14 | | |
| 18 | 27610-45-3 | SODIUM SULPHIDE HYDRATE | H2Na2OS | 96.06 | 50 °C | Soluble in water. Slightly soluble in alcohol. Insoluble in etherSoluble in water. Slightly soluble in alcohol. Insoluble in ether. |
| 19 | 27610-48-6 | 1,6-BIS(2,3-EPOXYPROPOXY)NAPHTHALENE | C16H16O4 | 272.3 | | 32.8mg/L at 20℃ |
| 20 | 27610-62-4 | 8-Bromopurine | C5H3Br N4 | | | |
| 21 | 27610-86-2 | 1,1'-bi(cyclopentyl)-3-one(SALTDATA: FREE) | C10H16O | 152.23 | | |
| 22 | 27610-88-4 | 2,2,7,7-tetraMethyl-3,6-octanedione | C12H22O2 | 198.3 | 1.3°C | |
| 23 | 27610-92-0 | 2-butyloctanoic acid | C12H24O2 | 200.32 | | 2.2mg/L at 20℃ |
| 24 | 2761004-85-5 | Benzo[b]thiophene-3-acetamide, α-[(2-chloroacetyl)[4-(5-oxazolyl)phenyl]amino]-N-(2-phenylethyl)- | C29H24ClN3O3S | 530.04 | | |
| 25 | 2761009-30-5 | CXCR4 antagonist 4 | | | | |
| 26 | 2761009-43-0 | 1,4-Butanediamine, N1-[[(7R)-5,6,7,8-tetrahydro-1,6-naphthyridin-7-yl]methyl]-N1-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- | | 365.52 | | |
| 27 | 2761010-72-2 | 1-(pentan-3-yl)indoline-2, 3-dione | | | | |
| 28 | 2761020-02-2 | 2761020-02-2 | C22H14O6 | 374.35 | | |
| 29 | 2761021-80-9 | Ifebemtinib tosylate | | | | |
| 30 | 2761039-04-5 | benzyl methyl(1,4-oxazepan-6-yl)carbamate hydrochloride | | | | |
| 31 | 2761039-76-1 | 2H-Tetrazole-5-carboxamide, 2-(1,1-dimethylethyl)-N-[[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]- (ACI) | | | | |
| 32 | 2761039-89-6 | Benzenemethanamine, α,2-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, hydrochloride (1:1), (αR)- | C15H25BClNO2 | 297.63 | | |
| 33 | 2761040-27-9 | 5-(tert-Butyl)-4-fluoroisoxazole-3-carboxylic acid | C8H10FNO3 | 187.17 | | |
| 34 | 2761045-11-6 | (5aS,6aR)-2-((5aS,6aR)-2',2'-Dimethyl-5a,6a-dihydro-5H-spiro[cyclopropa[4,5]cyclopenta[1,2-b]pyridine-6,5'-[1,3]dioxan]-2-yl)-2',2'-dimethyl-5a,6a-dihydro-5H-spiro[cyclopropa[4,5]cyclopenta[1,2-b]pyridine-6,5'-[1,3]dioxane | C28H32N2O4 | 460.57 | | |
| 35 | 2761046-45-9 | Revumenib Citrate | C32H47FN6O4S.C6H8O7.H2O | 840.96 | | |
| 36 | 2761048-02-4 | 1H-Cyclopenta[b]pyridine-3-carboxamide, 2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)octahydro-N-[4-methyl-3-(trifluoromethyl)phenyl]-, (2R,3S,4aR,7aR)- | C36H39F4N3O2 | 621.71 | | |
| 37 | 2761048-06-8 | 1H-Cyclopenta[b]pyridine-3-carboxamide, 2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)octahydro-N-(1-methyl-1H-indazol-5-yl)-, (2R,3S,4aR,7aR)- | C36H40FN5O2 | 593.73 | | |
| 38 | 2761048-50-2 | 1H-Cyclopenta[b]pyridine-3-carboxamide, 1-(2-fluoro-6-methylbenzoyl)octahydro-N-(1-methyl-1H-indazol-5-yl)-2-[4-[(tetrahydro-2H-pyran-4-yl)amino]phenyl]-, (2R,3S,4aR,7aR)- | C36H40FN5O3 | 609.73 | | |
| 39 | 2761059-09-8 | tert-butyl (1R,2S,3S,5S)-3-amino-2-fluoro-8-azabicyclo[3.2.1]octane-8-carboxylate | | | | |
| 40 | 2761060-49-3 | 2761060-49-3 | C15H13N3 | 235.29 | | |
| 41 | 2761063-79-8 | 3,3'-Bipyridine, 6-[2-(4-fluorophenyl)ethoxy]- | C18H15FN2O | 294.32 | | |
| 42 | 2761063-99-2 | Morpholine, 2-phenyl-4-[6-[[cis-3-(1H-pyrazol-1-yl)cyclobutyl]oxy]-4-pyrimidinyl]-, (2S)- | C21H23N5O2 | 377.44 | | |
| 43 | 2761064-11-1 | cis-3-(triazol-1-yl)cyclobutanol | C6H9N3O | 139.16 | | |
| 44 | 2761064-26-8 | trans-1-(3-bromocyclobutyl)-4-fluoro-pyrazole | C7H8BrFN2 | 219.06 | | |
| 45 | 2761064-32-6 | cis-3-(5-fluoropyrazol-1-yl)cyclobutanol | C7H9FN2O | 156.16 | | |
| 46 | 2761064-33-7 | cis-3-(3-chloropyrazol-1-yl)cyclobutanol | C7H9ClN2O | 172.61 | | |
| 47 | 2761064-34-8 | cis-3-(5-chloropyrazol-1-yl)cyclobutanol | C7H9ClN2O | 172.61 | | |
| 48 | 2761064-35-9 | trans-1-(3-bromocyclobutyl)-3-chloro-pyrazole | C7H8BrClN2 | 235.51 | | |
| 49 | 2761064-36-0 | trans-1-(3-bromocyclobutyl)-5-chloro-pyrazole | C7H8BrClN2 | 235.51 | | |
| 50 | 2761069-97-8 | 6-Bromo-2-(methylsulfinyl)-8,9-dihydroimidazo[1',2':1,6]pyrido[2,3-d]pyrimidine | C10H9BrN4OS | 313.17 | | |
| 51 | 2761070-91-9 | 3-Bromo-7-chloro-1,6-naphthyridin-2(1H)-one | C8H4BrClN2O | 259.49 | | |
| 52 | 2761071-11-6 | 3-Pyridazinecarboxylic acid, 5-(trifluoromethyl)-, methyl ester | C7H5F3N2O2 | 206.12 | | |
| 53 | 2761071-29-6 | 4-Pyridineacetonitrile, 2-bromo-α,α-dimethyl- | C9H9BrN2 | 225.09 | | |
| 54 | 2761081-30-3 | TBP-134 | | | | |
| 55 | 2761090-30-4 | 1-benzyl-3-bromo-4-methyl-pyrazole | C11H11BrN2 | 251.13 | | |
| 56 | 2761090-34-8 | 1-tetrahydropyran-2-yl-5-(trifluoromethyl)pyrazole | C9H11F3N2O | 220.2 | | |
| 57 | 2761090-44-0 | 4-[(5-bromo-3-methyl-pyrazol-1-yl)methyl]benzonitrile | C12H10BrN3 | 276.14 | | |
| 58 | 2761090-45-1 | 4-[(3-bromo-5-methyl-pyrazol-1-yl)methyl]benzonitrile | C12H10BrN3 | 276.14 | | |
| 59 | 2761090-46-2 | 5-bromo-3-methyl-1-(tetrahydropyran-4-ylmethyl)pyrazole | C10H15BrN2O | 259.15 | | |
| 60 | 2761090-47-3 | 3-bromo-5-methyl-1-(tetrahydropyran-4-ylmethyl)pyrazole | | | | |
| 61 | 2761090-48-4 | 2-benzyl-3-iodo-indazole | C14H11IN2 | 334.16 | | |
| 62 | 2761090-49-5 | 1-benzyl-5-bromo-3-methoxy-pyrazole | C11H11BrN2O | 267.13 | | |
| 63 | 2761090-50-8 | 1-ethyl-5-iodo-3-methoxy-pyrazole | C6H9IN2O | 252.06 | | |
| 64 | 2761091-61-4 | 1H-Indazole-3-methanol, 6-chloro-α-methyl- | C9H9ClN2O | 196.63 | | |
| 65 | 2761094-10-2 | 2,4-Morpholinedicarboxylic acid, 5-methyl-, 4-(1,1-dimethylethyl) ester, (2S,5R)- | C11H19NO5 | 245.27 | | |
| 66 | 2761094-12-4 | (2R,5R)-4-(tert-Butoxycarbonyl)-5-methylmorpholine-2-carboxylic acid | C11H19NO5 | 245.27 | | |
| 67 | 27611-01-4 | 2-decyltetradecyl laurate | C36H72O2 | 536.96 | | |
| 68 | 27611-39-8 | 5-Bromo-1H-indene-1,3(2H)-dione | C9H6BrO2 | 225.04 | | |
| 69 | 27611-63-8 | 2-CYANOBENZOYL CHLORIDE | C8H4ClNO | 165.58 | | |
| 70 | 2761146-51-2 | 5-Quinolinecarboxamide, N-(1-methylethyl)-2-(5,6,7-trifluoro-1H-indol-3-yl)- | C21H16F3N3O | 383.37 | | |
| 71 | 2761146-55-6 | methyl 3-amino-5-(cyclohexylamino)-1H-pyrazole-4-carboxylate | C11H18N4O2 | 238.29 | | |
| 72 | 2761147-94-6 | OXS007417 | | 369.34 | | |
| 73 | 2761149-17-9 | 4-(Phenylmethyl)-N-1H-pyrazolo[3,4-b]pyridin-3-yl-1-piperazinepropanamide | C20H24N6O | 364.44 | | |
| 74 | 2761149-22-6 | ChE/Aβ1-42-IN-1 | | | | |
| 75 | 2761152-16-1 | FHND5071 | C30H30D3N9O | 538.66 | | |
| 76 | 2761158-33-0 | Benzenesulfonic acid, 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxy- | C18H22N4O5S | 406.46 | | |
| 77 | 2761170-84-5 | 3-[5-(Aminomethyl)-6-fluoro-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione | C14H14FN3O3 | 291.28 | | |
| 78 | 2761172-60-3 | Benzamide, 4-[[4-[[4-[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenoxy]-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]-1-piperidinyl]methyl]- | C30H32N6O3 | 524.61 | | |
| 79 | 2761172-65-8 | Methanesulfonamide, N-[4-[4-[[4-[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenoxy]-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]-1-piperidinyl]phenyl]- | C29H32N6O4S | 560.67 | | |
| 80 | 2761180-01-0 | EGFR/c-Met-IN-2 | C27H23F2N5O4 | 519.5 | | |
| 81 | 2761181-58-0 | Benzamide, 5-chloro-N-[6-[(2R)-2,3-dihydroxypropoxy]-4-pyridazinyl]-2-(4-fluoro-2-methylphenoxy)-4-(trifluoromethyl)- | C22H18ClF4N3O5 | 515.84 | | |
| 82 | 2761187-73-7 | Turenkibart | | | | |
| 83 | 2761193-67-1 | 5-Methyl-2-[(3R)-3-methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-7-(1H-pyrazol-3-yl)imidazo[1,5-b]pyridazine | C19H22N8O | 378.43 | | |
| 84 | 2761194-15-2 | Cyclohexanecarboxamide, 1-[5-[(3R)-3-methyl-4-morpholinyl]-3-(5-methyl-1H-pyrazol-3-yl)isothiazolo[4,5-b]pyridin-7-yl]- | C22H28N6O2S | 440.56 | | |
| 85 | 2761194-66-3 | 3-bromo-5-chloro-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine | C10H7BrClN5 | 312.56 | | |
| 86 | 2761194-70-9 | methyl 2-(3-bromo-5-chloro-pyrazolo[1,5-a]pyrimidin-7-yl)-2-methylsulfonyl-acetate | C10H9BrClN3O4S | 382.61 | | |
| 87 | 2761195-46-2 | Imidazo[1,5-b]pyridazine, 2,4-dichloro- | C6H3Cl2N3 | 188.01 | | |
| 88 | 2761195-79-1 | Isothiazolo[4,5-b]pyridine, 3,7-dichloro-5-[(3R)-3-methyl-4-morpholinyl]- | C11H11Cl2N3OS | 304.2 | | |
| 89 | 27612-10-8 | 2-Methylsulfinyl phenothiazine | C13H11NOS2 | 261.36 | 193-195 °C | |
| 90 | 27612-67-5 | 1-ALLYL-4-(2-HYDROXYETHYL)-PIPERAZINE | C9H18N2O | 170.25 | | |
| 91 | 27612-79-9 | Silane, tris[(1,1-dimethylethyl)dioxy]-2-propenyl- | C15H32O6Si | 336.49648 | | |
| 92 | 2761204-87-7 | (2R,4aR)-10-(2-Amino-7-fluoro-4-benzothiazolyl)-11-fluoro-2,3,4,4a,6,8-hexahydro-2,6-dimethyl-8-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-3-(1-oxo-2-propen-1-yl)-1H-pyrazino[1′,2′:4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione | C34H32F2N8O3S | 670.73 | | |
| 93 | 2761205-38-1 | Anticancer agent 16 | | | | |
| 94 | 2761205-75-6 | Bempedoic Acid Impurity 57 | | | | |
| 95 | 2761211-49-6 | 2-Propen-1-one, 1-[(3S)-3-[4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]- | C24H21N7O2 | 439.47 | | |
| 96 | 2761212-93-3 | Benzothiazole, 5-ethynyl-6-fluoro-2-methyl- | C10H6FNS | 191.22 | | |
| 97 | 2761218-40-8 | KRAS inhibitor-11 | C29H47N9O6 | 617.74 | | |
| 98 | 2761225-71-0 | (R)-tert-Butyl (1-fluoro-3-phenylpropan-2-yl)carbamate | C14H20FNO2 | 253.32 | | |
| 99 | 2761225-79-8 | (S)-tert-Butyl (1-fluoro-4-methylpentan-2-yl)carbamate | C11H22FNO2 | 219.3 | | |
| 100 | 2761226-35-9 | Urea, N-[[1-(4-chloro-3-fluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl]methyl]-N′-[[1-(7-quinolinyl)-1H-1,2,4-triazol-5-yl]methyl]- | C23H19ClFN9O | 491.91 | | |
| 101 | 2761259-05-4 | Benzamide, N-(4-aminobutyl)-4-[[2-[(trans-4-aminocyclohexyl)amino]-9-cyclopentyl-9H-purin-6-yl]amino]- | C27H39N9O | 505.66 | | |
| 102 | 2761259-09-8 | Benzamide, N-(4-aminobutyl)-4-[[[2-[(trans-4-aminocyclohexyl)amino]-9-cyclopentyl-9H-purin-6-yl]amino]methyl]- | C28H41N9O | 519.68 | | |
| 103 | 2761259-22-5 | 9H-Purine-2,6-diamine, N6-[4-[(4-aminobutyl)amino]phenyl]-N2-(trans-4-aminocyclohexyl)-9-cyclopentyl- | C26H39N9 | 477.65 | | |
| 104 | 2761279-63-2 | StRIP16 | C116H154N24O26 | 2300.61 | | |
| 105 | 2761281-50-7 | 5-Pyrimidinecarboxamide, N-[4-[4-[[4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-1-piperazinyl]carbonyl]-1-piperidinyl]phenyl]-2-phenoxy- | C40H38N8O7 | 742.78 | | |
| 106 | 2761281-51-8 | PROTAC(H-PGDS)-8 | C41H40N8O7 | 756.81 | | |
| 107 | 2761282-96-4 | 2761282-96-4 | C18H12Cl3N4O3+ | 438.67 | | |
| 108 | 2761282-97-5 | 4H,6H-Indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium, 5a,10b-dihydro-9-nitro-2-(2,4,6-trichlorophenyl)-, (5aS,10bR)-, tetrafluoroborate(1-) (1:1) | C18H12BCl3F4N4O3 | 525.47 | | |
| 109 | 2761290-32-6 | Pyridine, 5-chloro-2-[(2S)-2-methyl-4-(4-piperidinyl)-1,3-benzodioxol-2-yl]-, hydrochloride (1:1) | C18H20Cl2N2O2 | 367.27 | | |
| 110 | 2761290-41-7 | Pyridine, 2-[[(6-bromo-2-pyridinyl)oxy]methyl]-5-chloro- | C11H8BrClN2O | 299.55 | | |
| 111 | 2761290-85-9 | 9-[1,1′-Biphenyl]-4-yl-N-(2-chlorophenyl)-9H-carbazol-3-amine | | | | |
| 112 | 27613-04-3 | Oxazolium,3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-,chloride (1:1) | C12H17N4O2.Cl | | | |
| 113 | 27613-27-0 | 3-Cyanophthalide | C9H5NO2 | 159.14 | 120-121 °C(Solv: ethanol (64-17-5); hexane (110-54-3)) | |
| 114 | 27613-33-8 | Phthalaldehydonitrile, 5-methyl- (8CI) | C9H7NO | 145.16 | | |
| 115 | 27613-34-9 | 3-Formyl-2-methylbenzonitrile | C9H7NO | 145.16 | | |
| 116 | 27613-35-0 | Benzonitrile, 4-formyl-2-methyl- (9CI) | C9H7NO | 145.16 | | |
| 117 | 27613-36-1 | Benzonitrile, 5-formyl-2-methyl- (9CI) | C9H7NO | 145.16 | | |
| 118 | 27613-37-2 | Phthalaldehydonitrile, 6-methyl- (8CI) | C9H7NO | 145.15798 | | |
| 119 | 27613-38-3 | Phthalaldehydonitrile, 4-methyl- (8CI) | C9H7NO | 145.16 | | |
| 120 | 27613-39-4 | Isophthalaldehydonitrile, 4-methyl- (8CI) | C9H7NO | 145.16 | | |
| 121 | 27613-46-3 | 1H,4H-3a,6a-Ethanopentalene, tetrahydro- | C10H16 | 136.23 | | |
| 122 | 27613-56-5 | 1,6-Epoxy-3H-cyclopropa[e]furo[3,4-g]isobenzofuran, decahydro- | C11H14O3 | 194.23 | | |
| 123 | 27613-59-8 | 2,5,8-Trioxa-1-silanonane | C5H14O3Si | 150.25 | | |
| 124 | 27613-72-5 | (2,4,5-TRICHLOROPHENOXY)-ACETICACIDBUTOXYPOLY-PROPYLENE. | | | | |
| 125 | 27613-77-0 | Poly(oxy-1,2-ethanediyl),a-acetyl-w-hydroxy- | C4H8O3 | 104.10452 | | |
| 126 | 27613-78-1 | 1,2-DIHYDROXYANTHRAQUINONE-3-SULFONIC ACID | C14H8O7S | 320.27 | | |
| 127 | 2761321-18-8 | 1H-Purine-2,6-dione, 8-[(acetyloxy)methyl]-7-[(3-bromophenyl)methyl]-3,7-dihydro-3-methyl- | C16H15BrN4O4 | 407.22 | | |
| 128 | 2761321-26-8 | 1H-Purine-2,6-dione, 8-bromo-1,7-bis[(4-bromophenyl)methyl]-3,7-dihydro-3-methyl- | C20H15Br3N4O2 | 583.07 | | |
| 129 | 2761326-82-1 | MEIS-IN-1 | C24H21F3N2O4 | 458.43 | | |
| 130 | 2761326-86-5 | MEIS-IN-2 | | | | |
| 131 | 2761326-88-7 | MEIS-IN-3 | | | | |
| 132 | 2761327-15-3 | YS-67 | C32H34N4O3 | 522.64 | | |
| 133 | 2761347-19-5 | Efparepoetin alfa | | | | |
| 134 | 2761347-44-6 | SSTR4 agonist 5 | | | | |
| 135 | 2761352-71-8 | 7H-Pyrrolo[2,3-d]pyrimidine-7-methanol, 4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]- | C14H17N5O2 | 287.32 | | |
| 136 | 2761366-60-1 | 2(1H)-Pyridinone, 4-ethoxy-1-methyl-5-[1-(phenylmethyl)-1H-indazol-6-yl]- | C22H21N3O2 | 359.42 | | |
| 137 | 2761367-25-1 | N-[3-(4-Fluorophenyl)-2-phenyl-1,2,4-thiadiazol-5(2H)-ylidene]methanamine | C15H12FN3S | 285.34 | | |
| 138 | 2761367-86-4 | Benzenepropanoic acid, 4-chloro-, 3-(1-piperidinyl)propyl ester | C17H24ClNO2 | 309.83 | | |
| 139 | 2761380-32-7 | KRAS G12C inhibitor 49 | C31H31ClN6O3 | 571.07 | | |
| 140 | 2761385-81-1 | Thalidomide-5-PEG3-NH2 hydrochloride | C19H23N3O7.ClH | 441.86 | | |
| 141 | 2761385-94-6 | Thalidomide-5-O-C5-NH2 hydrochloride | C18H21N3O5.ClH | 395.84 | | |
| 142 | 2761390-03-6 | 1H-Pyrrolo[2,3-c]pyridine-1-carboxylic acid, 5-(acetylamino)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester | C20H28BN3O5 | 401.26 | | |
| 143 | 2761394-06-1 | E3 Ligase Ligand-linker Conjugate 136 | | | | |
| 144 | 2761398-00-7 | 5-[4-(2-Aminoethyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione Dihydrochloride | | | | |
| 145 | 2761398-05-2 | Thalidomide-5-O-C6-NH2 hydrochloride | C19H23N3O5.ClH | 409.86 | | |
| 146 | 27614-26-2 | 4,7-Methano-5H-inden-5-one,1,3a,4,6,7,7a(or 3,3a,4,6,7,7a)-hexahydro- | C10H12O | 148.20168 | | |
| 147 | 27614-71-7 | [tetrachloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper | C32H12Cl4CuN8 | 713.86 | | |
| 148 | 2761406-70-4 | Thalidomide-5-PEG2-NH2 hydrochloride | C17H19N3O6.ClH | 397.81 | | |
| 149 | 2761410-17-5 | 5-[4-(4-Aminobutyl)-1-piperazinyl]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione Dihydrochloride | | | | |
| 150 | 2761418-75-9 | (S)-tert-Butyl (1-fluoro-4-phenylbutan-2-yl)carbamate | C15H22FNO2 | 267.34 | | |
| 151 | 2761418-78-2 | tert-Butyl (S)-(1-fluoro-3-methylbutan-2-yl)carbamate | C10H20FNO2 | 205.27 | | |
| 152 | 2761424-76-2 | mGluR5 antagonist-1 | C23H18N4O2 | 382.42 | | |
| 153 | 2761425-11-8 | 7-methyl-4-(phenylethynyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid ethyl ester | | | | |
| 154 | 2761425-12-9 | 7-methyl-4-(phenylethynyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | | | | |
| 155 | 2761425-15-2 | 4-((4-fluorophenyl)ethynyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid ethyl ester | | | | |
| 156 | 2761425-16-3 | 4-((4-fluorophenyl)ethynyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | | | | |
| 157 | 2761425-17-4 | 4-((4-methoxyphenyl)ethynyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid ethyl ester | | | | |
| 158 | 2761425-18-5 | 4-((4-methoxyphenyl)ethynyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | | | | |
| 159 | 2761425-21-0 | 7-methyl-4-((4-methylphenyl)ethynyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid ethyl ester | | | | |
| 160 | 2761425-22-1 | 7-methyl-4-((4-methylphenyl)ethynyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | | | | |
| 161 | 2761446-55-1 | 1-(17-Azido-3,6,9,12,15-pentaoxaheptadec-1-yl)-1H-imidazole | C15H27N5O5 | 357.41 | | |
| 162 | 2761446-60-8 | 2761446-60-8 | | | | |
| 163 | 2761446-81-3 | Insulin sensitizer C59 | C16H18Cl2N2O | 325.23 | | |
| 164 | 2761458-99-3 | heptadecan-9-yl 10-bromodecanoate | C27H53BrO2 | 489.61 | | |
| 165 | 2761478-98-0 | (2S,4R)-1-((R)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride | C22H31ClN4O3S | 467.03 | | |
| 166 | 2761478-99-1 | Maridebart | | | | |
| 167 | 2761502-58-1 | 4H-1,2,4-Triazolium, 1-[(2R,3R)-3-[4-(4-cyanophenyl)-2-thiazolyl]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-4-[1-[[[[3-(hydroxymethyl)-2-pyridinyl]methylamino]carbonyl]oxy]ethyl]- | C32H30F2N7O4S+ | 646.69 | | |
| 168 | 2761523-97-9 | 1-[3-(Methylamino)-1-azetidinyl]-2-propen-1-one (TFA) | | | | |
| 169 | 2761538-66-1 | AL-GDa62 | | | | |
| 170 | 2761541-59-5 | Z-DT-2Br-γ | C115H155Br2N9O2S4 | | | |
| 171 | 2761542-55-4 | 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1H-indol-5-ylamino)-2-oxoethyl]-, (2E)- | C20H19N3O4 | 365.38 | | |
| 172 | 2761571-76-8 | 7-bromo-2,12-di-tert-butyl-5-oxa-9-thia-13b-boranaphtho[3,2,1-de]anthracene | C26H26BBrOS | 477.27 | | |
| 173 | 2761572-96-5 | (1S,3R)-3-(Acetylamino)-N-[5-chloro-4-(3,4-dihydro-2H-1,4-benzoxazin-8-yl)-2-pyridinyl]cyclohexanecarboxamide | C22H25ClN4O3 | 428.91 | | |
| 174 | 2761577-50-6 | 2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- | C20H19ClN2O2 | 354.83 | | |
| 175 | 2761578-18-9 | 10H-Phenothiazine-10-propanamide, 2-chloro-N,N-bis(4-fluorophenyl)- | C27H19ClF2N2OS | 492.97 | | |
| 176 | 2761587-27-1 | AAK1-IN-3 TFA | | | | |
| 177 | 2761587-28-2 | AAK1-IN-2 TFA | | | | |
| 178 | 2761599-07-7 | 3-(((2-Formylphenyl)amino)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | C21H24BNO5 | 381.24 | | |
| 179 | 2761657-21-8 | STAT3-IN-43 | | | | |
| 180 | 2761677-54-5 | tert-Butyl (2R,5R)-5-cyano-2-methylpiperazine-1-carboxylate | | | | |
| 181 | 2761681-01-8 | 2761681-01-8 | C21H29ClFN5O7 | 517.94 | | |
| 182 | 2761695-59-2 | 3-(5-chloro-2-methoxyphenyl)-1-methyl-1,2,4-triazole Bisulfate Salt | C10H12ClN3O5S | 321.73 | | |
| 183 | 2761697-69-0 | TLR8 agonist 4 | | | | |
| 184 | 2761698-77-3 | 1,2-Benzenediol, 4-[4-(4-methyl-1-naphthalenyl)-3-pyridinyl]- | C22H17NO2 | 327.38 | | |
| 185 | 27617-34-1 | 1H,1H-PERFLUORO(2,5,8,11,14-PENTAMETHYL-3,6,9,12,15-OXAOCTADECAN-1-OL) | C18H3F35O6 | 980.16 | | |
| 186 | 2761723-61-7 | Cy5.5 NHS ester | | | | |
| 187 | 2761725-68-0 | Ethanimidamide, N-[3-hydroxy-3-(3-pyridinyl)propyl]- | C10H15N3O | 193.25 | | |
| 188 | 2761731-14-8 | 4-Morpholineethanol, 2,6-dimethyl-, 4-(4-aminobenzoate) | C15H22N2O3 | 278.35 | | |
| 189 | 2761733-03-1 | 2-hydroxy-N-phenyl-3-(p-tolylthio)propanamide | C16H17NO2S | 287.382 | | |
| 190 | 2761734-21-6 | DNA crosslinker 3 dihydrochloride | | | | |
| 191 | 2761734-23-8 | DNA crosslinker 4 dihydrochloride | | | | |
| 192 | 2761734-25-0 | DNA crosslinker 2 dihydrochloride | | | | |
| 193 | 2761734-27-2 | 2-(4-guanidinomethyl)benzyl-4-guanidinomethylpyridazin-3(2H)-one dihydrochloride | | | | |
| 194 | 2761736-66-5 | Anticancer agent 162 | | 780.64 | | |
| 195 | 2761767-18-2 | GJG057 | C21H21F5N4O2 | 456.41 | | |
| 196 | 2761768-49-2 | 2-Amino-6-(1,1-difluoroethyl)pyrimidin-4(1H)-one | | | | |
| 197 | 2761770-56-1 | Acid-PEG11-t-Bu Ester | | | | |
| 198 | 2761794-74-3 | AM-2-19 | | | | |
| 199 | 2761795-00-8 | Research Grade Fanastomig | | | | |
| 200 | 27618-10-6 | 2-amino-4-benzylphenol | C13H13NO | 199.25 | | |
| 201 | 27618-25-3 | 3-[(3-Methylphenyl)amino]propanenitrile | C10H12N2 | 160.22 | | |
| 202 | 27618-46-8 | 1-Propanone, 3-[4-(3-chlorophenyl)-1-piperazinyl]-1-(3,4,5-trimethoxyphenyl)-, hydrochloride (1:1) | C22H28Cl2N2O4 | 455.38 | | |
| 203 | 2761830-88-8 | 3-(4-Methoxyphenyl)oxetane-3-sulfonyl fluoride | | | | |
| 204 | 2761834-03-9 | 3-Oxetanesulfonyl fluoride, 3-(3,4-dimethoxyphenyl)- | C11H13FO5S | 276.28 | | |
| 205 | 2761858-59-5 | Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-[(2,4-dimethoxyphenyl)amino]-5,7-diphenyl- | C27H23N5O3 | 465.5 | | |
| 206 | 2761860-23-3 | 4-borono-2-(trifluoromethoxy)benzoic acid | | | | |
| 207 | 2761879-35-8 | Cyclopentanepropanenitrile, β-hydrazinyl-, (βR)- | C8H15N3 | 153.23 | | |
| 208 | 2761879-36-9 | (R)-3-cyclopentyl-3-hydrazinylpropanenitrile L-tartaric acid salt dihydrate | C12H21N3O6 | 303.32 | | |
| 209 | 2761879-41-6 | 7H-Pyrrolo[2,3-d]pyrimidine-4-acetaldehyde, α-(hydroxymethylene)-, (αE)- | C9H7N3O2 | 189.17 | | |
| 210 | 2761879-42-7 | 7H-Pyrrolo[2,3-d]pyrimidine, 2-methyl-, hydrochloride (1:1) | C7H8ClN3 | 169.61 | | |
| 211 | 2761879-51-8 | Ruxolitinib Impurity 17 | C12H21N3O6 | 303.32 | | |
| 212 | 2761881-65-4 | P-gp-IN-30 | | | | |
| 213 | 2761893-68-7 | 4-(benzo[d]oxazol-2-yl)-N-(4-(benzo[d]oxazol-2-yl)phenyl)-N-(4-chlorophenyl)aniline | | | | |
| 214 | 27619-87-0 | 3,3,4,4,4-pentafluorobutane-1-sulfonyl chloride | C4H4ClF5O2S | 246.58 | | |
| 215 | 27619-88-1 | 3,3,4,4,5,5,6,6,6-nonafluorohexane-1-sulphonyl chloride | C6H4ClF9O2S | 346.6 | | |
| 216 | 27619-89-2 | 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonyl chloride | C8H4ClF13O2S | 446.6134016 | | |
| 217 | 27619-90-5 | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecanesulphonyl chloride | C10H4ClF17O2S | 546.63 | | |
| 218 | 27619-91-6 | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecane-1-sulphonyl chloride | C12H4ClF21O2S | 646.64 | | |
| 219 | 27619-94-9 | Sodium 1H,1H,2H,2H-perfluorooctanesulfonate | C8H6F13NaO3S | 452.16 | | |
| 220 | 27619-96-1 | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-decanesulfonic Acid, Sodium Salt (in 50ug/mL) | C10H6F17NaO3S | 552.18 | | |
| 221 | 27619-97-2 | Perfluorohexyl Ethyl sulphonic acid | C8H5F13O3S | 428.17 | | 658g/L at 20℃ |
| 222 | 2761911-40-2 | 4-Phenanthridinamine, 5-ethyl-5,6-dihydro-8,9-dimethoxy- | C17H20N2O2 | 284.35 | | |
| 223 | 2761911-44-6 | Acetamide, N-(5-ethyl-5,6-dihydro-8,9-dimethoxy-4-phenanthridinyl)-2,2,2-trifluoro- | C19H19F3N2O3 | 380.36 | | |
| 224 | 2761913-41-9 | 2-Propenoic acid, 2-fluoro-3-[(2R)-1-methyl-2-pyrrolidinyl]-, hydrochloride (1:1), (2Z)- | C8H12FNO2.ClH | 209.65 | | |
| 225 | 2761915-35-7 | N,N-dimethyl-4-(4-phenyl-1H-pyrrol-2-yl)aniline | C18H18N2 | 262.36 | | |
| 226 | 2761920-93-6 | 8-(methylamino)-6-((2-oxo-2H-[1,2’-bipyridin]-3-yl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid | | | | |
| 227 | 2761920-94-7 | 1-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)pyridin-2(1H)-one | C12H18BNO3 | 235.09 | | |
| 228 | 2761921-00-8 | 6-chloro-8-((4-methoxybenzyl)(methyl-d3)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid | | | | |
| 229 | 2761921-16-6 | 8-((4-methoxybenzyl)(methyl)amino)-6-((2-oxo-2H-[1,2’-bipyridin]-3-yl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid | | | | |
| 230 | 2761921-45-1 | (R)-6-chloro-8-((4-methoxybenzyl)(methyl)amino)-N-(1-methyl-2-oxopyrrolidin-3-yl)imidazo[1,2-b]pyridazine-3-carboxamide | | | | |
| 231 | 2761921-46-2 | ethyl 6-chloro-8-((4-methoxybenzyl)(methyl-d3)amino)imidazo[1,2-b]pyridazine-3-carboxylate | | | | |
| 232 | 2761921-47-3 | Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, 2-amino-2-methylpropyl ester | C32H46N4O3 | 534.73 | | |
| 233 | 2761944-89-0 | tert-butyl (4-(bis(4-aminophenyl)amino)phenyl)carbamate | | | | |
| 234 | 2761947-05-9 | 1-Imidazolidineacetamide, 3-[[4-[2-(4-chloro-3,5-dimethylphenoxy)ethoxy]phenyl]methyl]-N-[(1S)-2-[[(4-chloro-3-nitrophenyl)sulfonyl]amino]-1-[[4-[(4-chlorophenyl)methoxy]phenyl]methyl]-2-oxoethyl]-2,5-dioxo- | C44H40Cl3N5O11S | 953.24 | | |
| 235 | 2761952-11-6 | 2(1H)-Pyridinone, 5-(cyclopropylmethyl)- | C9H11NO | 149.19 | | |
| 236 | 2761952-18-3 | 2-chloro-4-cyclopropyl-5-methylpyridine | C9H10ClN | 167.64 | | |
| 237 | 2761953-76-6 | 1H-1,2,3-Triazole-5-carboxylic acid, 4-hydroxy-1-[(4-methoxyphenyl)methyl]-, ethyl ester | C13H15N3O4 | 277.28 | | |
| 238 | 2761968-90-3 | tert-Butyl (3-cyano-7-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]thiophen-2-yl)carbamate | C20H24BFN2O4S | 418.29 | | |
| 239 | 2761968-93-6 | 2-Propen-1-one, 1-[3-[8-chloro-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1H-1,2,3-triazolo[4,5-c]quinolin-1-yl]-1-azetidinyl]- | C21H14ClF2N5O2 | 441.82 | | |
| 240 | 2761969-44-0 | Angiotensin II human TFA | | | | |
| 241 | 2761969-85-9 | N-(3,4-Dimethylphenyl)-2,3,3a,4,5,9b-hexahydro-4-[4-(2-methyl-1-oxopropyl)phenyl]furo[3,2-c]quinoline-8-sulfonamide | C29H32N2O4S | 504.64 | | |
| 242 | 2761976-81-0 | 1-(Cyclopropylmethyl)pyrazolo[3,4-d]pyrimidine-6-carboxylic Acid | | | | |
| 243 | 2761984-81-8 | 4,4,5,5-Tetramethyl-2-(spiro[bicyclo[4.1.0]heptane-3,2'-[1,3]dioxolan]-6-yl)-1,3,2-dioxaborolane | C15H25BO4 | 280.17 | | |
| 244 | 2761985-05-9 | 1-Benzyl 2-methyl 5-(difluoromethyl)-3-oxopyrrolidine-1,2-dicarboxylate | C15H15F2NO5 | 327.28 | | |
| 245 | 2761985-13-9 | 1-Benzyl 2-methyl 3-oxo-5-(trifluoromethyl)pyrrolidine-1,2-dicarboxylate | C15H14F3NO5 | 345.27 | | |
| 246 | 2761985-36-6 | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[4.1.0]heptan-3-one | C13H21BO3 | 236.12 | | |
| 247 | 2761985-48-0 | (2R,3S,3aR,6aR)-Methyl 3-amino-2-(hydroxymethyl)hexahydrocyclopenta[b]pyrrole-1(2H)-carboxylate | C10H18N2O3 | 214.27 | | |
| 248 | 2761991-42-6 | 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-[2-[[2-(5-methoxy-1H-indol-3-yl)ethyl]amino]-2-oxoethyl]-, (2E)- | C23H25N3O5 | 423.46 | | |